Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-21-000196
Filing Date
2021-09-22
Accepted
2021-09-22 18:15:22
Documents
1
Period of Report
2021-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163234890624036.html 4  
1 FORM 4 wf-form4_163234890624036.xml 4 33094
  Complete submission text file 0001651308-21-000196.txt   34568
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Huang Jane (Reporting) CIK: 0001683913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 211270476